CorePath Laboratories Partnered With Cizzle Biotechnology To Develop Simple Blood Test For Detecting Lung Cancer

CorePath Laboratories is excited for announcing a partnership with Cizzle Biotechnology, a diagnostic developer based in the United Kingdom for the purpose of developing and offering a priority in the early-stage lung cancer test throughout the United States of America. Lung Cancer has been the main cause of cancer deaths in the United States of […]

Continue Reading